Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-(hydroxymethyl)-2-methoxy- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

158089-31-7

Post Buying Request

158089-31-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

158089-31-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 158089-31-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,0,8 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 158089-31:
(8*1)+(7*5)+(6*8)+(5*0)+(4*8)+(3*9)+(2*3)+(1*1)=157
157 % 10 = 7
So 158089-31-7 is a valid CAS Registry Number.

158089-31-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(hydroxymethyl)-2-methoxybenzoic acid

1.2 Other means of identification

Product number -
Other names 4-hydroxymethyl-2-methoxybenzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:158089-31-7 SDS

158089-31-7Relevant academic research and scientific papers

ARYL AND HETEROARYL-CARBOXAMIDE SUBSTITUTED HETEROARYL COMPOUNDS AS TYK2 INHIBITORS

-

, (2021/10/15)

Novel carboxamide substituted compounds of Formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Tyrosine Kinase 2 (Tyk2).

A New Class of Nonpeptide Bradykinin B2 Receptor Ligand, Incorporating a 4-Aminoquinoline Framework. Identification of a Key Pharmacophore to Determine Species Difference and Agonist/Antagonist Profile

Sawada, Yuki,Kayakiri, Hiroshi,Abe, Yoshito,Mizutani, Tsuyoshi,Inamura, Noriaki,Asano, Masayuki,Aramori, Ichiro,Hatori, Chie,Oku, Teruo,Tanaka, Hirokazu

, p. 2667 - 2677 (2007/10/03)

Introduction of various aliphatic amino groups at the 4-position of the quinoline moiety of our nonpeptide bradykinin (BK) B2 receptor antagonists afforded highly potent ligands for human B2 receptor with various affinities for guine

5-SUBSTITUTED IMIDAZO[4,5-C]PYRIDINES

-

, (2008/06/13)

The present invention relates to a class of compounds represented by the formula STR1 or a pharmaceutically acceptable salt thereof useful in the treatment of diseases or disorders mediated by platelet activating factor (PAF).

REGIOSELECTIVE LITHIATION OF Π-(ARENE)CHROMIUM TRICARBONYL COMPLEXES

Uemura, Motokazu,Nishikawa, Naomi,Hayashi, Yuji

, p. 2069 - 2072 (2007/10/02)

Chromium tricarbonyl complexes of 3-methoxybenzyl alcohol and related compounds were selectively lithiated at the 4-position in contrast to the corresponding metal free arene compounds.The resulting 4-lithio complexes were converted to the 4-substituted arene compounds in moderate to excellent yields through the reaction with proper electrophiles and subsequent demetalation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 158089-31-7